glofitamab,odronextamab,epcoritamab
roche,regeneron,genmab,abbvie,regeneron
['glofitamab', 'odronextamab', 'epcoritamab', '$regn', '$abbv', '$rhhby']
$abbv epcoritamab again looks like the one to beat. 21 may 2023 pdufa date. meanwhile, $rhhby due to file glofitamab by ye 2022. $regn presenting odronextamab data at #ash22 right now. can step-up dosing mitigate the tox here? 
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.